Tramal, the drug produced by the "Grunenthal" firm (FRG) was used in the treatment of 478 patients with malignant neoplasms. In 24.46% patients, the side effects were noted, which were characteristic of the majority of analgetics and didn't threaten the life. The authors recommend to use Tramal for cupping off the pain syndrome at the postoperative period, and in incurable patients as well.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
[effectiveness analgesic
4
analgesic tramal
4
tramal treatment
4
patients
4
treatment patients
4
patients oncologic
4
oncologic diseases]
4
diseases] tramal
4
tramal drug
4
drug produced
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!